Document is current
Any future updates will be listed below
-
Authors
Gavriilaki, Eleni https://orcid.org/0000-0002-8883-8208
Papadopoulou, Anastasia
Touloumenidou, Tasoula
Stavridou, Fani
Koravou, Evaggelia-Evdoxia
Giannaki, Maria
Papalexandri, Apostolia
Karavalakis, Georgios
Batsis, Ioannis
Kourelis, Andreas
Chatzopoulou, Fani
Chatzidimitriou, Dimitrios
Sotiropoulos, Damianos
Yannaki, Evangelia
Sakellari, Ioanna
Anagnostopoulos, Achilles https://orcid.org/0000-0003-4384-9031
- License Information
-
More Information
Article History
Received: 9 December 2021
Revised: 1 April 2022
Accepted: 1 April 2022
First Online: 21 April 2022
Competing interests
: EG has consulted for Amyndas, Alexion, Omeros, and Sanofi Pharmaceuticals. EY has consulted for BlueBirdBio and Vertex/CrispRTherapeutics. Remaining authors declare no competing interests.
Free to read: This content has been made available to all.
